NATIONS FINANCIAL GROUP INC, /IA/ /ADV

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1109767 CEDAR RAPIDS, IA

Position in HALO

as of Mar 31, 2026 · filed Apr 15, 2026 Compact

Position Value

$980,889

-$28,207 QoQ

Shares Held

15,177

+1.2% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

NATIONS FINANCIAL GROUP INC, /IA/ /ADV holds $3,466,943 across 9 Biotechnology names. HALO ranks #2 (28.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	4,490	$2,004,964
2	HALO	Halozyme Therapeutics, Inc. This page	15,177	$980,889
3	NVCT	Nuvectis Pharma, Inc.	13,000	$100,490
4	VNDA	Vanda Pharmaceuticals Inc.	14,000	$96,740
5	IMRX	Immuneering Corp	17,000	$89,590
6	PGEN	Precigen, Inc.	15,500	$59,985
7	ANIX	Anixa Biosciences Inc	22,500	$58,050
8	HYPD	Hyperion Defi, Inc.	11,125	$38,381

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$980,889	15,177	+1.2%	Shares	Sole	2026-04-15
2025-12-31	$1,009,096	14,994	-1.1%	Shares	Sole	2026-01-26
2025-09-30	$1,111,834	15,160	+0.5%	Shares	Sole	2025-10-28
2025-06-30	$784,773	15,086	+4.6%	Shares	Sole	2025-08-11
2025-03-31	$920,714	14,429	+2.6%	Shares	Sole	2025-05-13
2024-12-31	$672,304	14,062	+2.4%	Shares	Sole	2025-01-30
2024-09-30	$786,134	13,734	+6.3%	Shares	Sole	2024-11-04
2024-06-30	$676,438	12,919	+36.9%	Shares	Sole	2024-07-29
2024-03-31	$383,978	9,439	+48.1%	Shares	Sole	2024-04-23
2023-12-31	$235,509	6,372	—	Shares	Sole	2024-02-09
No filing history on record for this holder in this stock.